VENORUTON 300

300MG CPS DUR 50

SÚKL code 0218100
Name of the product VENORUTON 300
_MA_MEDICATION_DETAIL_INFO_MED_NAME i VENORUTON 300
Supplement 300MG CPS DUR 50
Strenght 300MG
Pharmaceutical form Capsule, hard
Package 50
Route Oral use
Wrap type Blister
Legal status OTC medicinal products
Active substance OXERUTINS (OXERUTINA)
ATC group C05CA54
ATC group name TROXERUTIN, KOMBINACE

Marketing authorisation information

Registration Number 85/ 514/70-C
Type of MA National
MA status B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till)
Placed on the market till 31. 03. 2021
MA Holder GlaxoSmithKline Consumer Healthcare Czech Republic s.r.o., Praha
MA Holder country ČESKÁ REPUBLIKA
Actual MA holder STADA Arzneimittel AG, Bad Vilbel
Actual MA holder country NĚMECKO

Back to list